Seward simplifies cell preparation
Enhances applications for Strainer bags to include sterile processing of tissue samples
Gamma irradiated sterile and available in a range of sizes, the Strainer bags are compatible with all laboratory paddle blenders, including Seward’s Stomacher 80 Biomaster series. Because they are fully containable and easily used in a sterile environment, the Strainer bags can be used for new applications in cell culture.
The 0.5mm pore size of the integrated strainer element within the Seward Strainer bag generates a uniformly homogenous cell suspension, says the Worthing-based company. This allows the cells’ passage through the pores of the central straining matrix and prevents contamination with undigested extracellular material, which can block pipettes. Produced to provide a sterile, secure environment for the preparation of single cell suspensions, the Strainer bag is suitable for the individual processing of a large number of samples.
“The new life-science applications of our robust Strainer bag technology represent the continuing, customer oriented, development to which Seward is committed,” said Stuart Ray, technical director at Seward Ltd.
“Cell scientists can simplify their primary culture preparations by straining the processed tissues to ensure trouble-free pipetting, whilst also increasing the viability of the cells produced as the end product.”
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
Upcoming event
You may also like
Manufacturing
Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies
Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
Manufacturing
Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan
The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031